Page last updated: 2024-08-23

captopril and sb 203580

captopril has been researched along with sb 203580 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ciccarelli, C; Desideri, G; Evangelista, S; Ferri, C; Festuccia, C; Grassi, D; Gravina, GL; Lovat, F; Marampon, F; Polidoro, L; Scarsella, L; Zani, BM	1

Other Studies

1 other study(ies) available for captopril and sb 203580

Article	Year
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis. Journal of hypertension, 2013, Volume: 31, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Captopril; Cell Nucleus; Cell Survival; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; MAP Kinase Kinase 6; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Sirtuin 1; Superoxides	2013

Article

Year

Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis.

Journal of hypertension, 2013, Volume: 31, Issue:10

Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Captopril; Cell Nucleus; Cell Survival; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; MAP Kinase Kinase 6; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Sirtuin 1; Superoxides

2013